Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging

Neurobiology of Disease

Volumn 11, Issue 2, 2002, Pages 315-329

  Poduslo, Joseph F ^a   Wengenack, Thomas M ^a   Curran, Geoffry L ^a   Wisniewski, Thomas ^b   Sigurdsson, Einar M ^b   Macura, Slobodon I ^c   Borowski, Bret J ^d   Jack Jr , Clifford R ^d  

^a Molecular Neurobiology Laboratory   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c MAYO CLINIC ROCHESTER   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; GADOLINIUM; POLYAMINE; PUTRESCINE;

ALZHEIMER DISEASE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN REGION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; HIPPOCAMPUS; HISTOPATHOLOGY; IMAGING SYSTEM; MEMBRANE PERMEABILITY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENILE PLAQUE; TRANSGENIC MOUSE;

EID: 0036965918     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2002.0550     Document Type: Article

References (20)

1. Agdeppa, E. D., Kepe, V., Flores-Torres, S., Liu, J., Satyamurthy, N., Petric, A., Small, G. W., Huang, S. C., & Barrio, J. R. (2001) In vitro binding characteristics of FDDNP and a new analog for synthetic β-amyloid fibrils. J. Nucl. Med. 42, 64P-65P.
2. Bacskai, B. J., Kajdasz, S. T., Christie, R. H., Carter, C., Games, D., Seubert, P., Schenk, D., & Hyman, B. T. (2001) Imaging of amyloid-β deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy. Nat. Med. 7, 369-372.
3. Benveniste, H., Einstein, G., Kim, K. R., Hulette, C., & Johnson, A. (1999) Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy. Proc. Natl. Acad. Sci. USA 96, 14079-14084.
4. Constantinides, C. D., Rogers, J., Herzka, D. A., Boada, F. E., Bolar, D., Kraitchman, D., Gillen, J., and Bottomley, P. A. (2001) Super-paramagnetic iron oxide MION as a contrast agent for sodium MRI in myocardial infarction. Magn. Reson. Med. 46, 1164-1168.
5. Holcomb, L., Gordon, M. N., McGowan, E., Yu, X., Benkovic, S., Jantzen, P., Wright, K., Saad, I., Mueller, R., Morgan, D., Sanders, S., Zehr, C., O'Campo, K., Hardy, J., Prada, C.-M., Eckman, C., Younkin, S., Hsiao, K., & Duff, K. (1998) Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat. Med. 4, 97-100.
6. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274, 99-102.
7. Johnson, G. A., Thompson, M. B., and Drayer, B. P. (1987) Three-dimensional MRI microscopy of the normal rat brain. Mag. Res. Med. 4, 351-365.
8. Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) Copper, iron, and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158, 47-52.
9. Poduslo, J. F., & Curran, G. L. (1996a) Polyamine modification increases the permeability of proteins at the blood-nerve and blood-brain barriers. J. Neurochem. 66, 1599-1609.
10. Poduslo, J. F., & Curran, G. L. (1996b) Increased permeability of superoxide dismutase at the blood-nerve and blood-brain barriers with retained enzymatic activity after covalent modification with the naturally occurring polyamine, putrescine. J. Neurochem. 67, 734-741.
11. Poduslo, J. F., Curran, G. L., & Gill, J. S. (1998) Putrescine-modified NGF: Bioactivity, pharmacokinetics, blood-brain/nerve barrier permeability, and nervous system biodistribution. J. Neurochem. 71, 1651-1660.
12. Poduslo, J. F., Whelan, S. L., Curran, G. L., & Wengenack, T. M. (2000) Therapeutic benefit of polyamine-modified catalase as a scavenger of hydrogen peroxide and nitric oxide in familial amyotrophic lateral sclerosis transgenics. Ann. Neurol. 48, 943-947.
13. Poduslo, J. F., Curran, G. L., Wengenack, T. M., Malester, B., & Duff, K. (2001) Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease. Neurobiol. Dis. 8, 555-567.
14. Robb, R. A. (1990) A software sytem for interactive and quantitative analysis of biomedical images. In: 3D Imaging in Medicine (Hohne, K. H., Fuchs, H., & Pizer, S. M., Eds.), pp. 333-361. NATO ASI Series, Springer-Verlag, Berlin.
15. Selkoe, D. J. (2000) Imaging Alzheimer's amyloid. Nat. Biotechnol. 18, 823-824.
16. Shoghi-Jadid, K., Small, G. W., Agdeppa, E. D., Kepe, V., Ercoli, L. M., Siddarth, P., Read, S., Satyamurthy, N., Petric, A., Huang, S. C., and Barrio, J. R. (2002) Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. Am. J. Geriatric Psych. 10, 24-35.
17. Skovronsky, D. M., Zhang, B., Kung, M.-P., Kung, H. F., Trojanowski, J. Q., & Lee, V. M.-Y. (2000) In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 97, 7609-7614.
18. Wengenack, T. M., Curran, G. L., Olson, E. E., & Poduslo, J. F. (1997) Putrescine-modified catalase with preserved enzymatic activity exhibits increased permeability at the blood-nerve and blood-brain barriers. Brain Res. 767, 128-135.
19. Wengenack, T. M., Curran, G. L., & Poduslo, J. F. (2000a) Targeting Alzheimer amyloid plaques in vivo. Nat. Biotechnol. 18, 868-872.
20. Wengenack, T. M., Whelan, S. L., Curran, G. L., Duff, K. E., & Poduslo, J. F. (2000b) Quantitative histological analysis of amyloid deposition in Alzheimer's double transgenic mouse brain. Neuroscience 101, 939-944.